(Q42284132)

19 October 2017

A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection (English)

1 reference

19 October 2017

Akashi Togawa

1

1 reference

19 October 2017

Takanori Tanaka

2

1 reference

19 October 2017

Satoru Nagashima

3

1 reference

19 October 2017

Hiroyuki Keta

4

1 reference

19 October 2017

Yasue Kobayashi

5

1 reference

19 October 2017

Yasuhiro Nishikawa

6

1 reference

19 October 2017

Masanobu Yanai

7

1 reference

19 October 2017

Hideji Tanaka

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

British Journal of Clinical Pharmacology

19 October 2017

1 reference

19 October 2017

58

1 reference

19 October 2017

3

1 reference

19 October 2017

269-276

1 reference

After 15 years of success--perspectives of erythropoietin therapy

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Lymphatic transport of proteins after subcutaneous administration

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

26 October 2017

Erythropoietin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Design of biological equivalence programs for therapeutic biotechnology products in clinical development: a perspective

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Pharmacokinetics of endogenous substances: some problems and some solutions

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Clinical use of serum erythropoietin determination by the recombigen EPO RIA kit

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884567

Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection

17 August 2018

1 reference

12 December 2020

A case of anaphylaxis to gelatin included in erythropoietin products

1 reference

12 December 2020

Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers

1 reference

12 December 2020

Open questions in bioequivalence

1 reference

12 December 2020

Endogenous erythropoietin correlates with blood pressure in essential hypertension

1 reference

12 December 2020

Circadian rhythm of erythropoietin in human serum

1 reference

12 December 2020

Circadian rhythm of serum erythropoietin in healthy subjects

1 reference

12 December 2020

10.1111/J.1365-2125.2004.02151.X

Identifiers

DOI

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

15327586

1 reference